Innovation in Harm Reduction: PMI's Path to Progress

PMI by 2FIRSTS.ai

Dec.14.2023

Innovation in Harm Reduction: PMI's Path to Progress

Philip Morris International (PMI) advocates for harm reduction strategies to combat smoking-related health consequences, according to Branislav Bibic, VP of Africa at PMI.

According to a recent report by the foreign media outlet IOL, Branislav Bibic, Vice President of Africa for Philip Morris International, has stated that history has proven that civilized societies make steady progress through the advancement of innovation. He further explained that due to these innovations, improvements aimed at reducing harm in everyday behavior and activities have now become commonplace.

He pointed out that Philip Morris International company (PMI) advocates for the application of the harm reduction (THR) strategy to known smoking risks. He also emphasized especially that the best choice for any smoker is to completely quit tobacco and nicotine.

He stated that public health institutions, expert organizations, and the general public are increasingly using innovation to address the serious health consequences of smoking. For example, the US FDA has created separate channels for innovative tobacco products that are considered better than cigarettes and has approved their marketing as appropriate alternatives for promoting public health.

References:

[1] Reducing tobacco harm for public health

Also Read:

[1] PMI Recognized in Dow Jones Sustainability World Index

[2] PMI CFO Emmanuel Babeau Discusses Strong Growth at Investor Conference

[3] PMI Appoints Travis Parman as US Vice President

#Traditional tobacco #Legislation #Africa #PMI #Harm reduction products #Tobacco harm reduction products

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

BAT Pauses U.S. Launch of Unlicensed Vuse One Vape amid FDA Crackdown — Reuters

British American Tobacco has paused the U.S. pilot launch of its unlicensed Vuse One vape amid intensified FDA enforcement.

Oct.28 by 2FIRSTS.ai

Russian Lawmaker Sounds Alarm as Teenage Vaping Surges—Female Use Overtakes Male

Russia’s Chair of the State Duma Committee on Youth Policy warns that among 11–14-year-olds, girls now vape at higher rates than boys, a trend he calls “deeply concerning.” He says the spread of nicotine products—especially e-cigarettes—among minors poses a public health risk and warrants continued policy-level interventions.

Oct.17 by 2FIRSTS.ai

2Firsts Co-Founder and CEO Alan Zhao Speaks at PouchEX 2025: Highlighting China’s Critical Role in the Global Nicotine Pouch Industry

At PouchEX 2025 in Sweden, 2Firsts CEO Alan Zhao delivered an invited keynote, outlining China’s critical role in the global nicotine pouch industry from both supply chain and consumer insight perspectives, drawing significant attention from the international community.

Nov.17

Organigram Global Appoints Former BAT Global Head of Strategy James Yamanaka as Chief Executive Officer

Organigram Global has named James Yamanaka, previously Global Head of Strategy at British American Tobacco (BTI), as its new CEO. His appointment is expected to take effect around January 15, 2026, and he will also join the company’s board. Yamanaka brings more than 20 years of strategic and managerial experience from roles across Europe and Asia at BTI.